Search Results 971-980 of 17418 for Interferon
Factor VIIa is used to treat and prevent bleeding episodes in patients with Hemophilia A or B who have formed antibodies against other clotting proteins (eg, ...
ROCHESTER, Minn. — Mayo Clinic researchers have identified a specific immune cell that can be targeted to give a boost to standard immunotherapies for ...
Krull AA, DiGuardo MA, Deeds MC, Skaer CA, Soiney KA, Wadewitz M, Wiltshire TD, Gastineau DA, Dietz AB, Jacob EK. Fellowship training for cellular therapy ...
Regenerative biotherapeutics: Pivoting toward a new strategy for fighting disease featured image · Targeted immunotherapy helps Florida woman beat Lynch syndrome ...
First Efficacy Study of Investigational Antiviral Therapy for COVID-19 Infection in Patients with IBD · Science Saturday: Mayo Clinic study indicates U.S. rural ...
This randomized phase III trial is studying maintenance chemotherapy to see how well it works compared to observation following induction chemotherapy and ...
ROCHESTER, Minn. — Photon therapy offers strong outcomes in treating oropharyngeal cancers; however, some radiation can reach and damage nearby healthy ...
The objectives of this study are to determine whether adequate blood volumes can be obtained with the Tasso+ device for anti-HLA antibody testing, to compare ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.